KITCHENER, ON , Nov. 26, 2025 /PRNewswire/ - FluidAI Medical, a medical technology company that develops novel hardware, software, and artificial intelligence (AI) solutions, today announced an acquisition deal with SparxConnect developer Emmetros Limited, a leading company in the patient engagement space. The acquisition enhances Stream Inara™, an AI-powered patient education and engagement platform within FluidAI's product portfolio that extends care beyond the hospital. This is FluidAI's second acquisition deal after Medsix. Strategic acquisitions remain a core part of FluidAI's growth strategy, strengthening its position in existing markets and expanding its footprint with established products and technologies.

Stream Inara™ is part of FluidAI's Recovery Intelligence and Surgica

See Full Page